ErikssonH.Heart failure: a growing public health problem. J Int Med1995; 237: 135–41.
2.
Joint National Committee.The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. NIH Publication No. 98-4080, 1997.
3.
MosterdA.Heart failure in the population at large; news from the real world. Eur Heart J1999; 20: 398–9.
4.
ClelandJGF.Heart failure: a medical hydra. Lancet1998; 352 Suppl 1:1–2.
2000 heart and stroke statistical update.Dallas: American Heart Association, 1999.
7.
RichMW.Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J Am Geriatr Soc1997; 45: 968–74.
8.
RemesJ, ReunanenA, AromaaA, PyoralaK.Incidence of heart failure in eastern Finland: a population-based surveillance study. Eur Heart J1992; 13: 588–93.
9.
LambertsH, BrouwerHJ, MohrsJ.Reason for encounter - an episode and process oriented standard output from the Transition Project. Part 1 & 2. Amsterdam: Dept. of General Practice, 1993.
10.
Van de LisdonkEH, Van den BoschWJHM, HuygenFJA, Lagro-JansenALM.Diseases in general practice.Utrecht, the Netherlands: Bunge, 1990.
11.
Royal College of General Practitioners, Office of Population Census and Survey, and Department of Health and Social Security. Morbidity statistics from general practice: fourth national study, 1991-92. London: HMSO, 1995.
12.
ErikssonH, SvardsuddK, LarssonB.Risk factors for heart failure in the general population. The study of men born in 1913. Eur Heart J1989; 10: 647–56.
13.
MoserDK.Heart failure in women. Crit Care Nurs Clin North Am1997; 9: 511–9.
14.
SytkowskiPA, KannelWB, D'AgostinoRB.Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med1990; 322: 1635–41.
15.
LenfantC.Report of the Task Force on research in heart failure. Circulation1994; 90: 1118–23.
16.
HoKK, AndersonKM, KannelWB, GrossmanW, LevyD.Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation1993; 88: 107–15.
17.
CochranA, WilsonBA.Current management of AIDS and related opportunistic infections. Medsurg Nurs1999; 8: 257–64.
18.
MoreauP.Autologous stem cell transplantation for AL amyloidosis: a standard therapy?Leukemia1999; 13: 1929–31.
19.
CoatsAJS.Is preventive medicine responsible for the increasing prevalence of heart failure?Lancet1998; 352 Suppl 1:39–41.
20.
ClarkAL, CoatsAJ.New evidence for improved survival in chronic heart failure. Clin Cardiol1994; 17: 55–8.
21.
LipGYH, GibbsCR, BeeversDG.ABC of Heart Failure: aetiology. Br Med J2000; 320: 104–7.
22.
LipGYH, SarwarS, AhmedI.A survey of heart failure in general practice. The West Birmingham Heart Failure Project. Eur J Gen Pract1997; 3: 85–9.
23.
SharpeN, DoughtyR.Epidemiology of heart failure and ventricular dysfunction. Lancet1998; 352 Suppl 1:3–7.
24.
ErhardtLR, ClineCMJ.Organisation of the care of patients with heart failure. Lancet1998; 352 Suppl 1:15–18.
25.
ClelandJGF.Health economic consequences of the pharmacological treatment of heart failure. Eur Heart J1998; 19 Suppl P: P32–P39.
26.
McMurrayJ, HartW.The economic impact of heart failure on the UK National Health Service. Eur Heart J1993; 14 Suppl: 133.
27.
Ryden-BergstenT, AnderssonF.The health care costs of heart failure in Sweden. J Intern Med1999; 246: 275–84.
28.
McMurrayJ.Reduced costs with bisoprolol treatment for heart failure: an economic analysis of the second cardiac insufficiency bisoprolol study (CIBIS II). Abstract, European Society of Cardiology, Barcelona, August 1999.